Brief: Freeline Receives Approval To Transfer To Nasdaq Capital Market

Freeline Therapeutics Holdings

29/11/2022 21:07

Nov 29 (Reuters) - Freeline Therapeutics Holdings PLC
 FRLN.O :
    * FREELINE RECEIVES APPROVAL TO TRANSFER TO NASDAQ CAPITAL
MARKET

Source text for Eikon:  ID:nGNX39qfRM 
Further company coverage:  FRLN.O 
 ((Reuters.Briefs@thomsonreuters.com))